Status:

COMPLETED

Neck Exercises in Patients With Temporomandibular Disorders

Lead Sponsor:

University of Alberta

Conditions:

Temporomandibular Disorders

Temporomandibular Joint Pain

Eligibility:

FEMALE

18-60 years

Phase:

NA

Brief Summary

Musculoskeletal (MSK) pain is a common reason to seek medical treatment. Temporomandibular disorders (TMDs) are MSK disorders that affect the masticatory muscles, the temporomandibular joint, and rela...

Detailed Description

To treat musculoskeletal disorders, looking at the brain is an unusual strategy but one with high potential for effectiveness. Exercise can potentially train the brain if we understand the links betwe...

Eligibility Criteria

Inclusion

  • females 18-60 years of age (TMDs are more prevalent in females);
  • diagnosed with muscle pain disorders as classified by the new Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) or mixed TMD;
  • have had pain in the masticatory muscle for at least 3 months;
  • have chronic masticatory muscle pain not attributable to recent acute trauma, previous infection, or active inflammation; and
  • have a moderate or severe baseline pain score of 30 mm or greater using a 100 mm VAS.

Exclusion

  • metabolic, rheumatoid, or vascular diseases;
  • commonly comorbid functional chronic pain disorders (e.g., irritable bowel syndrome, fibromyalgia);
  • psychiatric disorders (e.g., depression, schizophrenia);
  • abnormal neurological examination;
  • contraindication for MRI scanning (e.g., metallic surgical implant);
  • self-report of substance abuse;
  • exercise therapy in the 6 months before entry into the study or current treatment for TMD;
  • previous experience with electrotherapy; or
  • pregnant or planning a pregnancy.
  • After confirming eligibility to participate in the study, all participants will be asked to sign an informed consent in accordance with the UofA´s policies on research using human participants.

Key Trial Info

Start Date :

January 17 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 20 2024

Estimated Enrollment :

113 Patients enrolled

Trial Details

Trial ID

NCT03403998

Start Date

January 17 2018

End Date

December 20 2024

Last Update

November 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Corbett Hall-Sports Laboratory

Edmonton, Alberta, Canada, T6G 0V1